Bacterial particles retard tumor growth as a novel vascular disrupting agent

被引:7
|
作者
Guo, Fengzhu [1 ,2 ,3 ,4 ]
Ji, Gaili [1 ,2 ,3 ]
Li, Qiqi [1 ,2 ,3 ]
Yang, Yun [1 ,2 ,3 ]
Shui, Lin [1 ,2 ,3 ]
Shen, Yuge [1 ,2 ,3 ]
Yang, Hanshuo [1 ,2 ,3 ]
机构
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Sichuan, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[4] Sichuan Univ, Lung Canc Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Bacterial particle; Vascular disrupting agent; Tumor microenvironments; Inflammatory cytokines; TARGETED THERAPY; CANCER; CELLS; ANGIOGENESIS; VEGF; RECRUITMENT; MECHANISMS; RESISTANCE; HYPOXIA;
D O I
10.1016/j.biopha.2019.109757
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Due to hypoxia and poor circulation in the tumor interior, malignant cells in solid tumors are resistant to traditional therapies. In the present study, we reported that bacterial particles (BactPs) functioned effectively in retarding tumor growth as a novel vascular disrupting agent. The BactPs were inactivated intact bacteria. Intravenous administration of BactPs extensively disrupted vessels in the tumor interior, but not in normal organs, and resulted in tumor hemorrhage and necrosis in six hours. We revealed that the extensive disruption of tumor vasculature was due to drastic changes in the inflammatory factors in mice sera and the tumor micro-environments, indicating the critical role of the host immune response to the BactPs. Furthermore, we showed that a combination of six inflammatory cytokines was capable of inducing tumor hemorrhage and necrosis, similar to the effects of the BactPs. Together, these results suggest that BactPs are a novel kind of tumor vascular disruptor with a promising potential for solid tumor treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] NPI-2358 is a tubulin-depolymerizing agent: in-vitro evidence for activity as a tumor vascular-disrupting agent
    Nicholson, B
    Lloyd, GK
    Miller, BR
    Palladino, MA
    Kiso, Y
    Hayashi, Y
    Neuteboom, STC
    ANTI-CANCER DRUGS, 2006, 17 (01) : 25 - 31
  • [42] Detection of Tumor Response to a Vascular Disrupting Agent by Hyperpolarized 13C Magnetic Resonance Spectroscopy
    Bohndiek, Sarah E.
    Kettunen, Mikko I.
    Hu, De-en
    Witney, Timothy H.
    Kennedy, Brett W. C.
    Gallagher, Ferdia A.
    Brindle, Kevin M.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (12) : 3278 - 3288
  • [43] Biphasic anti-tumoral effect of a vascular-disrupting agent triggering STING and tumor regression
    Weiss, Julia M.
    Guerin, Marion
    Regnier, Fabienne
    Thoreau, Maxime
    Peranzoni, Elisa
    Feuillet, Vincent
    Renault, Gilles
    Guilbert, Thomas
    Trautmann, Alain
    Bercovici, Nadege
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [44] ASA404, a novel tumor vascular disrupting agent (VDA): rationale for advanced non-small cell lung cancer therapy
    Lara, Primo N.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S41 - S41
  • [45] Assessment of novel benzosuberene-based vascular disrupting agents (VDA) on diverse tumor lines
    Liu, Li
    Trawick, Mary Lynn
    Pinney, Kevin
    Mason, Ralph Peter
    CANCER RESEARCH, 2016, 76
  • [46] EFFECTS OF COMBRETASTATIN-A4-PHOSPHATE, A NOVEL VASCULAR DISRUPTING AGENT, ON ENDOTHELIUM-DEPENDENT VASODILATATION
    Su, J.
    Laursen, B. E.
    Eskildsen-Helmond, Y.
    Horsman, M.
    Simonsen, U.
    HYPERTENSION, 2009, 54 (05) : 1186 - 1186
  • [47] ASA404 Vascular-Disrupting Agent Oncolytic
    Ching, L. M.
    DRUGS OF THE FUTURE, 2008, 33 (07) : 561 - 569
  • [48] VERUBULIN HYDROCHLORIDE Apoptosis Inducer Vascular Disrupting Agent Oncolytic
    Thomas, P.
    Recht, L.
    DRUGS OF THE FUTURE, 2010, 35 (12) : 993 - 997
  • [49] NANOFORMULATION OF A VASCULAR DISRUPTING AGENT FOR THE TREATMENT OF GLIOMA WITH MRI MONITORING
    Ali, Meser
    Jayasundara, Sunalee
    deCarvalho, Ana
    Ewing, James
    NEURO-ONCOLOGY, 2017, 19 : 24 - 25
  • [50] Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton
    Kim, Sujeong
    Peshkin, Leonid
    Mitchison, Timothy J.
    PLOS ONE, 2012, 7 (07):